• Liam Noah posted an update in the group Group logo of HealthHealth 1 week, 3 days ago

    A Questionable 3-Year-Study Is Indicating That Common Diabetes Drug, Canagliflozin, With Brand Name, Invokana Could Also Reduce Risks Of Kidney Diseases And Cardiovascular Deaths In Folks With Type 2 Diabetes And Chronic Kidney Disease. But The Side Effects Of Invokana Could Be An Increased Risk Of Lower Limb Amputation And Bone Fracture.

    Advertisement

About us   |  FAQ  |  Contact us   |  Copyright ©2017-2019  eFor-Real.com  |   Privacy  |   Terms of Service

   
Do NOT follow this link or you will be banned from the site!
This is a social network for those interested in unique and valuable information!

Log in with your credentials

Forgot your details?